America’s obesity crisis meets the Ozempic boom as data reveals GLP-1 hot spots
With new agreements from President Donald Trump promising lower prices on popular weight-loss drugs, the use of GLP-1 medications such as Ozempic and Mounjaro could soon surge even higher —…